Primary Effusion Lymphoma (pel) - Cancer Science

Relevant Publications

Promising immunotherapeutic approaches for primary effusion lymphoma.

Issue Release: 2024

Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.

Issue Release: 2024

The cellular Notch1 protein promotes KSHV reactivation in an Rta-dependent manner.

Issue Release: 2024

LKB1 suppresses KSHV reactivation and promotes primary effusion lymphoma progression.

Issue Release: 2024

5-AZA Upregulates SOCS3 and PTPN6/SHP1, Inhibiting STAT3 and Potentiating the Effects of AG490 against Primary Effusion Lymphoma Cells.

Issue Release: 2024

Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus.

Issue Release: 2024

Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA.

Issue Release: 2024

Inflammasome activation in patients with Kaposi sarcoma herpesvirus (KSHV)-associated disorders.

Issue Release: 2024

PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma.

Issue Release: 2024

Combined Flow-Fluorescence in situ hybridization to HHV-8 and EBV reveals the viral heterogeneity of primary effusion lymphoma.

Issue Release: 2024

Extracavitary primary effusion lymphoma presenting as a solitary brain mass.

Issue Release: 2024

Sequencing of Kaposi\'s Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance.

Issue Release: 2024

Discovery of a small-molecule inhibitor of KSHV lytic replication from the MMV Pandemic Response Box.

Issue Release: 2024

Primary Effusion Lymphoma Secondary to Human Herpesvirus 8 (HHV-8) Infection in an Immunocompetent Host: A Case Report.

Issue Release: 2024

Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden.

Issue Release: 2024

Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines.

Issue Release: 2024

HHV-8-associated diseases in transplantation: A case report and narrative review focused on diagnosis and prevention.

Issue Release: 2024

Biologically significant interaction of human herpesvirus 8 viral interferon regulatory factor 4 with ubiquitin-specific protease 7.

Issue Release: 2024

KSHV infection of B cells primes protective T cell responses in humanized mice.

Issue Release: 2024

The role of autologous bone marrow transplantation in primary effusion lymphoma: a case report and literature review.

Issue Release: 2024

How Can Clinicians and Researchers Benefit from JCO?

How Do Market Dynamics Affect Patient Access to Treatments?

What Challenges Exist in Providing Specialized Cancer Care?

What is the role of corporate sponsorships in cancer fundraising?

What signs and symptoms are healthcare providers looking for?

How Are Cancerous Moles Treated?

What Are the Current Applications and Future Prospects?

How Do Pharmacy Networks Improve Patient Outcomes?

What is the Role of Public Health in Cancer Prevention?

What is Gestational Trophoblastic Disease (GTD)?

Partnered Content Networks

Relevant Topics